ReviewAJR. American journal of roentgenology2017
Imaging Surveillance After Primary Breast Cancer Treatment.
Review in AJR. American journal of roentgenology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
32 citing papers in PubMed, 2 syntheses or guidelines pooled it, 78 citations in OpenAlex.
- The impact of mammographic breast density on locoregional recurrence in breast cancer: a systematic review and meta-analysis.Breast cancer research and treatment · 2025Pooled it
- Interval brain imaging for adults with cerebral glioma.The Cochrane database of systematic reviews · 2019Pooled it
- Computed Tomography Colonography vs Colonoscopy for Colorectal Cancer Surveillance After Surgery.Gastroenterology · 2018Trial
- [European journal of nuclear medicine and molecular imaging · 2026Article
- Multicenter Assessment of Postoperative MastocheckCancers · 2026Article
- ESR Essentials: post-treatment breast cancer surveillance from mammography to a more personalised approach-practice recommendations by the European Society of Breast Imaging.European radiology · 2026Review
- Contrast-Enhanced Mammography in Breast Cancer Follow-Up: Diagnostic Value in Suspected Recurrence.Journal of imaging · 2025Article
- Comparison of contrast-enhanced cone-beam breast CT, MRI, and mammography for breast cancer characterization.European radiology · 2025Article
- Surveillance Outcomes by Imaging Methods in the First 5 Years After Breast Cancer Surgery.Korean journal of radiology · 2025Article
- Correlation between variant allele frequency and mean tumor molecules with tumor burden in patients with solid tumors.Molecular oncology · 2024Article
- Contrast-enhanced mammography for surveillance in women with a personal history of breast cancer.Breast cancer research and treatment · 2024Article
- MR-contrast enhanced mammography (CEM) for follow-up of breast cancer patients: a "pros and cons" debate.European radiology · 2024Article
- False negative breast cancers on imaging and associated risk factors: a single institution six-year analysis.Breast cancer research and treatment · 2024Article
- Frequency and Outcomes of BI-RADS Category 3 Assessments in Patients With a Personal History of Breast Cancer: Full-Field Digital Mammography Versus Digital Breast Tomosynthesis.AJR. American journal of roentgenology · 2023Article
- The usefulness of a three-protein signature blood assay (Mastocheck®) for follow-up after breast cancer surgery.Journal of cancer research and clinical oncology · 2023Article
- Contrast enhanced mammography in breast cancer surveillance.Breast cancer research and treatment · 2023Article
- Mammographic calcifications undergoing percutaneous biopsy: outcome in women with and without a personal history of breast cancer.La Radiologia medica · 2023Article
- Imaging Surveillance Options for Individuals With a Personal History of Breast Cancer:AJR. American journal of roentgenology · 2022Review
- The value of time-dependent risk predictions in a screening context - a comprehensive simulation analysis validated on German cancer registry data.BMC medical research methodology · 2022Article
- Breast MRI in patients after breast conserving surgery with sentinel node procedure using a superparamagnetic tracer.European radiology experimental · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 2 countries.
Funding
Abstract
objectiveCurrent clinical guidelines are consistent in supporting annual mammography for women after treatment of primary breast cancer. Surveillance imaging beyond standard digital mammography, including digital breast tomosynthesis (DBT), breast ultrasound, and MRI, may improve outcomes. This article reviews the evidence on the performance and effectiveness of breast imaging modalities available for surveillance after treatment of sporadic unilateral primary breast cancer and identifies additional factors to be considered when selecting an imaging surveillance regimen.
conclusionEvidence review supports the use of mammography for surveillance after primary breast cancer treatment. Variability exists in guideline recommendations for surveillance initiation, interval, and cessation. DBT offers the most promise as a potential modality to replace standard digital mammography as a front-line surveillance test; a single published study to date has shown a significant decrease in recall rates compared with standard digital mammography alone. Most guidelines do not support the use of whole-breast ultrasound in breast cancer surveillance, and further studies are needed to define the characteristics of women who may benefit from MRI surveillance. The emerging evidence about surveillance imaging outcomes suggests that additional factors, including patient and imaging characteristics, tumor biology and gene expression profile, and choice of treatment, warrant consideration in selecting personalized posttreatment imaging surveillance regimens.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.